Cargando…
Natural Resistance of Leishmania infantum to Miltefosine Contributes to the Low Efficacy in the Treatment of Visceral Leishmaniasis in Brazil
In India, visceral leishmaniasis (VL) caused by Leishmania donovani has been successfully treated with miltefosine with a cure rate of > 90%. To assess the efficacy and safety of oral miltefosine against Brazilian VL, which is caused by Leishmania infantum, a phase II, open-label, dose-escalation...
Autores principales: | Carnielli, Juliana B. T., Monti-Rocha, Renata, Costa, Dorcas Lamounier, Molina Sesana, Aretha, Pansini, Laura N. N., Segatto, Marcela, Mottram, Jeremy C., Costa, Carlos Henrique Nery, Carvalho, Sílvio F. G., Dietze, Reynaldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779219/ https://www.ncbi.nlm.nih.gov/pubmed/31436148 http://dx.doi.org/10.4269/ajtmh.18-0949 |
Ejemplares similares
-
A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis
por: Carnielli, Juliana B.T., et al.
Publicado: (2018) -
3′Nucleotidase/nuclease is required for Leishmania infantum clinical isolate susceptibility to miltefosine
por: Carnielli, Juliana B.T., et al.
Publicado: (2022) -
Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil
por: dos Santos Nogueira, Fabio, et al.
Publicado: (2019) -
In Vitro Susceptibility to Miltefosine of Leishmania infantum (syn. L. chagasi) Isolates from Different Geographical Areas in Brazil
por: Espada, Caroline Ricce, et al.
Publicado: (2021) -
Leishmania infantum and Human Visceral Leishmaniasis, Argentina
por: Barrio, Alejandra, et al.
Publicado: (2012)